Exercise capacity, hemodynamic, and neurohumoral changes following acute and chronic administration of flosequinan in chronic congestive heart failure-Reference-Cited by-同舟云学术

Exercise capacity, hemodynamic, and neurohumoral changes following acute and chronic administration of flosequinan in chronic congestive heart failure

Published:1990-09 Issue:5 Volume:4 Page:1395-1402
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drug Ther

Author:

Riegger Günter A. J.,Kahles Heinz,Wagner Andreas,Kromer Eckhard P.,Elsner Dietma,Kochsiek Kurt

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF02018268.pdf

Reference16 articles.

1. The Captopril-Digoxin Multicenter Research Group. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure.JAMA 1988; 259:539–544.

2. The Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).N Engl J Med 1987;316:1429–1435.

3. Packer M, Lee WH, Kessler PD, et al. Identification of hyponatremia as a risk factor for the development of functional renal insufficiency during converting enzyme inhibition in severe chronic heart failure.J Am Coll Cardiol 1987;10: 837–844.

4. Franciosa JA, Weber KT, Levine TB, et al. Hydralazine in the long-term treatment of chronic heart failure: Lack of difference from placebo.Am Heart J 1982;104:587–594.

5. Markham RV, Corbett JR, Gilmore A, et al. Efficacy of prazosin in the management of chronic congestive heart failure: A 6-month randomized, double-blind placebo-controlled study.Am J Cardiol 1983;51:1346–1352.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Effects of Flosequinan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure;JACC: Heart Failure;2017-06

2. F;Hagers Handbuch der Pharmazeutischen Praxis;1999

3. Effects of Balanced Vasodilator, Flosequinan, on Aortic Impedance in Failing Heart;Journal of Cardiovascular Pharmacology;1998-09

4. Hemodynamic and neurohormonal effects of flosequinan in patients with heart failure;Fundamental & Clinical Pharmacology;1997-01-02

5. Actions of the Novel Vasodilator, Flosequinan, in Isolated Ventricular Cardiomyocytes;Journal of Cardiovascular Pharmacology;1995-03